Diagnostic imaging firm RadNet, by way of DeepHealth, its wholly-owned subsidiary, has acquired AI ultrasound imaging firm See-Mode Applied sciences.
See-Mode’s AI-powered ultrasound detection, characterization and reporting utility for thyroid and breast can be built-in into RadNet’s DeepHealth inhabitants well being choices.
In response to RadNet, See-Mode’s authentic functions for detecting and characterizing thyroid nodules and breast lesions in ultrasound imaging “enhance diagnostic accuracy and improve scientific workflows by producing standardized reviews.”
“Early deployment of See-Mode’s FDA-approved thyroid ultrasound AI throughout a portion of our imaging facilities has demonstrated as much as a 30% discount in scan time because of elevated workflow effectivity from See-Mode’s automated detection and reporting,” Dr. Howard Berger, president and CEO of RadNet, stated in an announcement.
“With demand exceeding obtainable appointment slots for a lot of of our over 900 ultrasound models, the rise in capability created by See-Mode’s expertise ought to enhance our capacity to drive higher entry and extra income by means of RadNet’s present facilities.”
THE LARGER TREND
In 2024, Give Healthcare and DeepHealth collaborated on an AI imaging expertise to additional innovation, commercialization and adoption of AI in imaging.
As a part of the collaboration, the businesses stated they might co-develop Sensible Expertise options that leverage the facility of AI to deal with obstacles throughout the imaging worth chain, akin to imaging interpretation effectivity, reporting and facilitating collaboration throughout care groups, enhancing the scientific interpretation of pictures and strengthening operational effectivity and productiveness.
In 2022, Volpara Well being Applied sciences signed a use contract with RadNet for the deployment of Volpara Analytics and Volpara Danger Pathways software program throughout RadNet’s 353 imaging facilities in seven U.S. states. In 2024, See-Mode obtained 510(okay) clearance from the FDA for an AI-powered providing to detect and diagnose thyroid points in ultrasound scans.
A yr earlier than, See-Mode obtained regulatory approvals in Australia and New Zealand for its AI-powered breast and thyroid ultrasound providing.
